Literature DB >> 13654547

The use of a sequestrene-citrate mixture in the estimation of the blood sedimentation rate.

I D MELVILLE, B M RIFKIND.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS/effects; BLOOD SEDIMENTATION/determination; EDATHAMIL/effects

Mesh:

Substances:

Year:  1959        PMID: 13654547      PMCID: PMC479911          DOI: 10.1136/jcp.12.3.258

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  8 in total

1.  Primary atypical pneumonia and high sedimentation rates.

Authors:  H J GALBRAITH; K W JONES
Journal:  Br Med J       Date:  1958-05-17

2.  A new anticoagulant for routine laboratory procedures; a comparative study.

Authors:  C H SCHMIDT; M E HANE; D C GOMEZ
Journal:  U S Armed Forces Med J       Date:  1953-11

3.  Use of sequestrene as an anticoagulant.

Authors:  G G HADLEY; N L LARSON
Journal:  Am J Clin Pathol       Date:  1953-06       Impact factor: 2.493

4.  Disodiumethylenediamine-tetra-acetate; an anticoagulant for routine hematological work.

Authors:  A M WITTGENSTEIN
Journal:  Am J Med Technol       Date:  1953 Mar-Apr

5.  A cell-suspension mixer.

Authors:  G A MATTHEWS
Journal:  J Clin Pathol       Date:  1951-08       Impact factor: 3.411

6.  An anomaly of the sedimentation rate in rheumatic diseases.

Authors:  S GOLDBERG; L E GLYNN; E G L BYWATERS
Journal:  Br Med J       Date:  1952-01-26

7.  Westergren and Wintrobe methods of estimating ESR compared.

Authors:  D GILMOUR; A J SYKES
Journal:  Br Med J       Date:  1951-12-22

8.  Anti-coagulant properties of ethylene bis-iminodiacetic acid.

Authors:  F PROESCHER
Journal:  Proc Soc Exp Biol Med       Date:  1951-04
  8 in total
  2 in total

1.  Sedimentation Rate of Stored Blood, using Sequestrene as the Anticoagulant.

Authors:  I D Melville; B M Rifkind
Journal:  Br Med J       Date:  1960-01-09

2.  Polystyrene ESR tubes.

Authors:  N W England; D E Warren; S Rycroft
Journal:  J Clin Pathol       Date:  1978-03       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.